Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.81 | 1.42 |
NAV | ₹97.62 | ₹1836.62 |
Fund Started | 31 Jul 2008 | 08 Dec 1994 |
Fund Size | ₹5254.65 Cr | ₹65966.82 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 16.15% | 17.91% |
3 Year | 23.68% | 22.07% |
5 Year | 22.08% | 22.45% |
1 Year
3 Year
5 Year
Equity | 95.78% | 87.15% |
Cash | 4.22% | 12.09% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.80% |
Infosys Ltd. | 4.66% |
ICICI Bank Ltd. | 4.14% |
State Bank of India | 3.76% |
Dr. Reddy's Laboratories Ltd. | 3.44% |
ITC Ltd. | 3.27% |
Bharti Airtel Ltd. | 2.97% |
Tech Mahindra Ltd. | 2.78% |
Biocon Ltd. | 2.75% |
Larsen & Toubro Ltd. | 2.47% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.62% |
ICICI Bank Ltd. | 9.56% |
Axis Bank Ltd. | 8.10% |
Kotak Mahindra Bank Ltd. | 4.44% |
Cipla Ltd. | 4.42% |
Maruti Suzuki India Ltd. | 4.09% |
SBI Life Insurance Company Ltd. | 4.06% |
Bharti Airtel Ltd. | 3.91% |
HCL Technologies Ltd. | 3.67% |
Piramal Pharma Ltd. | 2.91% |
Name | Satish Ramanathan | Dhruv Muchhal |
Start Date | 01 Oct 2024 | 14 Sep 2023 |
Name
Start Date
Description | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 31 Jul 2008 | 08 Dec 1994 |
Description
Launch Date